CVS peers and competitors
CVS Health Corp. · end-of-day data as of Oct 16, 2026
CVS Health Corp.
$92.36-14.3%
Buy · 27 analystsPT $111.66 +20.9%
CVS’s peers by industry and size include UnitedHealth Group (UNH), Vertex Pharmaceuticals (VRTX) and Bristol-Myers Squibb (BMY). Among these 12 companies CVS ranks 5th by market cap ($118B); its P/E of 24.4 compares with a median of 23.1 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $401.43 | -1.3% | -7.4% | +14.6% | 22.9 | $360B | |
| 2 |  | $499.74 | -1.8% | -10.4% | +14.0% | 29.1 | $127B | |
| 3 |  | $59.75 | -1.4% | -11.3% | +9.4% | 13.2 | $122B | |
| 4 |  | $94.75 | -0.7% | -7.1% | +4.0% | 23.3 | $121B | |
| 5 | | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 6 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 7 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 8 |  | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 9 |  | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 10 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 11 |  | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | |
| 12 |  | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B |
Data as of Oct 16, 2026 close.